Comparison among Vitamin D Levels in Associate with PCOS Variables in Women

Alaa R. M. Chyad

Alaa R. M. Chyad Sience Departement, College of Basic Education, Mustansiriyah University, Baghdad- Iraq

Keywords: polycystic- ovary/ovarian syndrome, vitamin D deficiency, BMI, hormone.

Abstract

Vitamin D deficiency is a condition that has been linked to an amplified hazard of acquiring Polycystic Ovary Syndrome in females. The objective of this investigation was to look at vitamin D deficiency in women with PCOS, also to see if there is a physiological function and effect on some of the bio-chemical indicators and the interaction between them. In this case study, there are two groups:80women with PCOS plus20normal women as a healthy controls. Serum hormonesFSH,LH,EstrogenE2,and Testosterone plus serum vit.D were measured in wholly research members using contemporary biochemical procedures. The results reveled that serum vit.D were significantly minor in patients by PCOS P = 0.00005compared with control group. The serum concentration of vit.D was meaningfully inferior in obese women with PCOS compared with non-obese women, meanwhile, concentrations of serum vit.D were shown to be favorably linked with(BMI),(P = 0.03).In conclusions, when compared to healthy women, there was no significant increase in the average stages of FSH,LH,andE2 in any group of PCOS women. In addition, the concentration of vit.D was substantially positively associated with the age of women with PCOS and BMI, not find any correlation between serum vit.D concentration with infertility duration,FSH,LH,E2,and Testosterone hormones in both women with PCOS and the group’s control, and the study not find any correlation between serum vit.D concentration with infertility duration, FSH, LH, E2,and Testosterone hormones in both women with PCOS and the control group .Vitamin D deficiency is common in PCOS women in Iraq. Especially in those with a high BMI. its impact on hormonal regulation may be limited.

References

Escobar-Morreale, H.F., 2018. Polycystic ovary syndrome: definition, a etiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), p.270.
El Hayek, S., Bitar, L., Hamdar, L.H., Mirza, F.G. and Daoud, G., (2016). Poly cystic ovarian syndrome: an updated overview. Frontiers in physiology, 7, p.124.
Barry, J.A., Azizia, M.M. and Hardiman, P.J., (2014). Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction update, 20(5), pp.748-758.
Ranjzad, F., Mahban, A., Shemirani, A.I., Mahmoudi, T., Vahedi, M., Nikzamir, A. and Zali, M.R., 2011. Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. Journal of assisted reproduction and genetics, 28(3), pp.225-232.
Trummer, C., Pilz, S., Schwetz, V., Obermayer-Pietsch, B. and Lerchbaum, E.,(2018). Vitamin D, PCOS and androgens in men: a systematic review. Endocrine Connections, 7(3), pp.R95-R113.
Rafiq, S., & Jeppesen, P. B. (2018). Body mass index, vitamin D, and type 2 diabetes: a systematic review and meta-analysis. Nutrients, 10(9), 1182.
Yildizhan, R., Kurdoglu, M., Adali, E., Kolusari, A., Yildizhan, B., Sahin, H. G., & Kamaci, M. (2009). Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Archives of gynecology and obstetrics, 280(4), 559-563.
Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., ... & Lee, P. A. (2017). An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Hormone research in paediatrics, 88, 371-395.
Holick, M. F. (2017). The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders, 18(2), 153-165.
Hu, Z., Jin’an Chen, X. S., Wang, L., & Wang, A. (2019). Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: a meta-analysis of interventional studies. Medicine, 98(14).
Fang, F., Ni, K., Cai, Y., Shang, J., Zhang, X., & Xiong, C. (2017). Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complementary therapies in clinical practice, 26, 53-60.
Muscogiuri, G., Policola, C., Prioletta, A., Sorice, G., Mezza, T., Lassandro, A., ... & Giaccari, A. (2012). Low levels of 25 (OH) D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?. Clinical Nutrition, 31(4), 476-480.
Peterson, C. A., Tosh, A. K., & Belenchia, A. M. (2014). Vitamin D insufficiency and insulin resistance in obese adolescents. Therapeutic advances in endocrinology and metabolism, 5(6), 166-189.
Veldurthy, V., Wei, R., Oz, L., Dhawan, P., Jeon, Y. H., & Christakos, S. (2016). Vitamin D, calcium homeostasis and aging. Bone research, 4(1), 1-7.
Ng, B. K., Lee, C. L., Lim, P. S., Othman, H., & Ismail, N. A. M. (2017). Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome. Hormone molecular biology and clinical investigation, 31(3).
Li, H. W. R., Brereton, R. E., Anderson, R. A., Wallace, A. M., & Ho, C. K. (2011). Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism, 60(10), 1475-1481.
Thomson, R. L., Spedding, S., & Buckley, J. D. (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical endocrinology, 77(3), 343-350.
Kumar, A., Barki, S., Raghav, V., Chaturvedi, A., & Kumar, K. H. (2017). Correlation of Vitamin D with metabolic parameters in polycystic ovarian syndrome. Journal of family medicine and primary care, 6(1), 115.
Kensara, O. A. (2018). Prevalence of hypovitaminosis D, and its association with hypoadiponectinemia and hyperfollistatinemia, in Saudi women with naïve polycystic ovary syndrome. Journal of clinical & translational endocrinology, 12, 20-25.
Min, Z. (2020). Protein Lysine Acetylation in Ovarian Granulosa Cells Affects Metabolic Homeostasis and Clinical Presentations of Women With Polycystic Ovary Syndrome. Frontiers in Cell and Developmental Biology, 8. https://doi.org/10.3389/fcell.2020.567028